March Biosciences

Description

Develops clinical-stage CAR-T cell therapies, including MB-105, aimed at difficult hematological cancers, with a focus on relapsed or refractory T-cell malignancies.

Related

• Allterum TherapeuticsDevelops 4A10, an anti-CD127 monoclonal antibody for cancers with CD127 expression, aiming to treat acute lymphoblastic leukemia, B-cell…
• Caribou Biosciences ($CRBU)Develops genome-edited allogeneic CAR-T cell therapies using CRISPR and chRDNA technology for patients with hematologic malignancies and…
• ArsenalBioDevelops in vivo T cell therapies and reprogrammed CAR T approaches for chronic diseases, including cancer and autoimmunity, with focus on…
• Cartesian Therapeutics ($RNAC)Develops clinical-stage mRNA cell therapies designed to treat autoimmune diseases, aiming to expand access to cell therapy for patients…
• G1 TherapeuticsDevelops and delivers cancer therapies for people living with cancer, with a focus on optimizing chemotherapy, advancing survival, and…
• Legend Biotech ($LEGN)CAR-T cell therapy company behind ciltacabtagene autoleucel and next-generation cell-therapy programs. Public via $LEGN (NASDAQ).
• Kyverna Therapeutics ($KYTX)Develops CAR T-cell therapies for autoimmune diseases, with clinical trials addressing conditions including stiff person syndrome and…
• Boundless Bio ($BOLD)Develops ecDNA-directed cancer therapies that target vulnerabilities in cancer cells for patients with intractable oncogene-amplified…
• BMS Cell Therapy Washington ($BMY)Develops, manufactures, and commercializes cancer immunology and cell therapies for people with difficult-to-treat cancers and other…
• Kanvas BiosciencesBuilds microbiome drug discovery and spatial mapping technology to image host-microbiome interactions and develop clinical-stage therapies…
• HexemBioBuilds rejuvenated stem cell therapy aimed at improving aged hematopoietic stem cells and bone marrow transplant outcomes for blood cancer…
• H. Lee Moffitt Cancer CenterNCI-designated comprehensive cancer center. Significant translational research in immunotherapy, cellular therapy (CAR-T), and AI-driven…